Literature DB >> 19395454

Arterial wall dysfunction in systemic lupus erythematosus.

A Cypiene1, M Kovaite, A Venalis, J Dadoniene, R Rugiene, Z Petrulioniene, L Ryliskyte, A Laucevicius.   

Abstract

Carotid-radial pulse wave velocity (PWV), aortic augmentation index (AIx) and endothelium-dependent flow-mediated dilatation (FMD) have been repeatedly showed to be related to premature atherosclerosis and cardiovascular diseases in different settings of population. The increased arterial stiffness and endothelium dysfunction may add to premature aging of the arteries in systemic lupus erythematosus (SLE) patients. Still data about arterial stiffness and endothelium function in inflammatory rheumatic diseases are not well described. The aim of this study was to determine the PWV, its derivate marker AIx and FMD and factors possibly influencing them in young SLE women without significant organ damage. Thirty women between 23 and 55 years with an established SLE diagnosis and 66 healthy women were consequently included in the study and both groups were comparable according to age, body mass index (BMI), serum lipid profile and creatinine. PWV was determined by measuring carotid-radial pulse wave transit time with the help of applanation tonometry and AIx, its derivate marker, was calculated as a difference between two waveform peaks expressed as a percentage of the pulse pressure. The FMD was performed by obtaining the repeated scans of the brachial artery at rest and during reactive hyperemia. In SLE women, PWV and AIx were significantly higher and FMD was not different from controls. In linear multiple stepwise regression analysis if patients and controls were both considered, PWV was weakly related to mean blood pressure (MBP), AIx was mostly predicted by age and MBP and FMD was predicted by the diameter of blood vessel, BMI, high density lipoproteins. If the sole SLE setting was analyzed, PWV was not related to any of the pending parameters, AIx turned out to be related to organ damage measured by Systemic Lupus International collaborative Clinics (SLICC) index and age, and FMD obtained strong and significant relation with vessel diameter, and BMI, and disease duration. Regardless of the small number of study group patients, we can state that controlling for MBP and taking measures towards organ damage prevention can partially slow down the process of early atherosclerosis in SLE patients.

Entities:  

Mesh:

Year:  2009        PMID: 19395454     DOI: 10.1177/0961203308099625

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus.

Authors:  Nur Canpolat; Ozgur Kasapcopur; Salim Caliskan; Selman Gokalp; Meltem Bor; Mehmet Tasdemir; Lale Sever; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2012-10-10       Impact factor: 3.714

2.  Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.

Authors:  Konstantinos Tziomalos; Ioannis Gkougkourelas; Alexandros Sarantopoulos; Eleni Bekiari; Evangelia Makri; Nikolaos Raptis; Konstantinos Tselios; Marianna Pantoura; Apostolos I Hatzitolios; Panagiota Boura
Journal:  Rheumatol Int       Date:  2016-11-21       Impact factor: 2.631

3.  Endovascular Treatment of Spontaneous Intracranial Internal Carotid Dissection in a Young Patient Affected by Systemic Lupus Erythematosus: A Case Report.

Authors:  Sergio Racchiusa; Marcello Longo; Gianmarco Bernava; Antonio Pitrone; Rosario Papa; Francesca Granata; Giuseppe Centorrino; Sergio Lucio Vinci
Journal:  J Vasc Interv Neurol       Date:  2017-10

4.  Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus.

Authors:  Marta Vadacca; Enrico M Zardi; Domenico Margiotta; Amelia Rigon; Fabio Cacciapaglia; Luisa Arcarese; Francesca Buzzulini; Antonio Amoroso; Antonella Afeltra
Journal:  Intern Emerg Med       Date:  2011-11-30       Impact factor: 3.397

5.  Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  De-Guang Wang; Xiao-Wu Tang; Ye Fan; Rui-Xue Leng; Jing Ni; Sen-Miao Deng; Chao Wang; Han Cen; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 6.  Assessment of Cardiac Risk in Women with Autoimmune Disease.

Authors:  Tyler Schmidt; Rekha Mankad
Journal:  Curr Cardiol Rep       Date:  2022-05-07       Impact factor: 3.955

Review 7.  Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Authors:  Vítor Teixeira; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2018-01-29

8.  Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.

Authors:  Anselm Mak; Nien Yee Kow; Herbert Schwarz; Lingli Gong; Sen Hee Tay; Lieng Hsi Ling
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

Review 9.  Management of cardiovascular disease in patients with systemic lupus erythematosus.

Authors:  Paramarjan Piranavan; Andras Perl
Journal:  Expert Opin Pharmacother       Date:  2020-06-08       Impact factor: 3.889

Review 10.  Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.

Authors:  Luca Zanoli; Marie Briet; Jean P Empana; Pedro G Cunha; Kaisa M Mäki-Petäjä; Athanase D Protogerou; Alain Tedgui; Rhian M Touyz; Ernesto L Schiffrin; Bart Spronck; Philippe Bouchard; Charalambos Vlachopoulos; Rosa M Bruno; Pierre Boutouyrie
Journal:  J Hypertens       Date:  2020-09       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.